This is the real settling down
10/29/2015 02:42:00 AM
I am perhaps affected by my original family, and thus I always have a dream about owning my sweet home. In this dream, I have a dearest husband, two adorable angels, and a cozy house. When I went out alone every weekend, I saw so many pictures on the street—young couples with their baby strollers. These were the most beautiful scenes in my mind.
How to do the injections for ovarian stimulation
10/19/2015 06:25:00 PM
I
am not nurse. How can I do the injections for myself?
The
automatic injection pen is wildly used. You just need to remember four steps—
1. Load the
medicine cartridge
2. Check the
prescribed dose
3. Place the
needle on the pen
4. Inject
the medicine
More
details about the injections are as follows,
A. Puregon
(MSD): see the animation of manual injection
It is one
kind of short-acting recombinant follicle-stimulating hormone (rFSH), and is mostly injected daily.
B.
Gonal-f(Merch): see the animation of manual injection
It is one
kind of short-acting rFSH, and is mostly injected daily.
C.
Elonva(MSD) : see the animation of manual injection
It is one kind of long-acting rFSH, and it supports multi-follicle growth up to seven days.
It is one kind of short-acting recombinant luteinizing hormone (rLH), and is used in the
patients with lower serum LH levels.
E.
Cetrotide (0.25mg): see the animation of manual injection
It
is a short-acting GnRH antagonist, and is used in the patients with higher
serum LH levels to prevent premature LH surge.
Common Genetic Variant Linked to IVF Failure
10/15/2015 08:36:00 PM
Original source: http://www.medscape.com/viewarticle/852455
Neil Osterweil
October 09, 2015
A genetic variant commonly found in women is strongly associated with chromosomal abnormalities that can lead to the failure of in vitro fertilization (IVF), investigators report.
Q&A of Egg Freezing
10/01/2015 09:02:00 PM
l Q and A:
1.
Do I have enough eggs to cyropreserve?
A. The amount of female oocytes is decreasing with the
maternal age. The cut-off value of the decline rate is around the age
35: the rate is comparative faster in the women over 35 than those under 35. AMH is a stable and
representative predictor: higher the level is, more the oocytes are.
2.
Will the controlled ovarian stimulation affect my own ovarian function?
A. The components of stimulation medication are
recombinant gonadotropins, which play the similar roles of external hormones to
support multiple follicle growth. If no medications were used, the external
hormone can only support a single follicle growth, called as the dominant
follicle, and the other subordinate follicles (15-20 varied with the
age) will degenerate in this menstrual cycle.
3.
Will the stimulation medication push me toward the menapause faster?
A. Since the medications just rescue the subordinate
follicles to become dominant, no additional stock are triggered. So the answer
is "no."
4.
Is it painful to get the injection?
A. Most injections are subcutaneous, and the injection
site are at lower hip or lower abdomen, where are not hypersensitive.
5.
Is the retrieval operation difficult?
A. Since the
introduction of sonographically guided viginal oocyte retrieval, the
double-lumen needle can go through the route without penetrating the
hypersensitive areas, and the diameter of needle is greatly reduced. The
anesthesia is recommended in the nervous cases.